表紙
市場調査レポート

神経インターベンション装置:医療機器のパイプライン評価

Interventional Neurology - Medical Devices Pipeline Assessment, 2015

発行 GlobalData 商品コード 350913
出版日 ページ情報 英文 192 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
神経インターベンション装置:医療機器のパイプライン評価 Interventional Neurology - Medical Devices Pipeline Assessment, 2015
出版日: 2016年01月01日 ページ情報: 英文 192 Pages
概要

当レポートでは、世界の神経インターベンション装置 (介入性神経学装置、神経インターベンション) の市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • インターベンショナル神経学市場の概要

第3章 インターベンショナル神経学市場:治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 神経インターベンション装置の企業:治験段階別のパイプライン製品
  • 神経インターベンション装置:治験段階別のパイプライン製品

第5章 神経インターベンション装置市場:企業・製品の概要

  • Alcyone Lifesciences, Inc.
    • パイプライン製品および進行中の治験の概要
  • Aneuclose LLC
  • Apeliotus Technologies
  • Arterain Medical Inc.
  • Avantec Vascular Corporation
  • Cibiem, Inc.
  • Codman & Shurtleff, Inc.
  • Collagen Matrix, Inc.
  • Cordis Corporation
  • CranioVation
  • Dartmouth College
  • DePuy Companies
  • EchoGuide Medical, Inc.
  • EKOS Corporation
  • Gaudi Vascular, Inc.
  • Hansjorg Wyss Institute for Biologically Inspired Engineering
  • Hibernia Medical
  • Insera Therapeutics, LLC
  • InspireMD, Inc.
  • ITGI Medical Ltd.
  • Lazarus Effect, Inc
  • Medikit Co., Ltd.
  • Merlin MD Pte. Ltd.
  • Metactive Medical, LLC
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • MindFrame Inc. (Inactive)
  • Neuravi Limited
  • NeuroInterventional Therapeutics, Inc.
  • NeuroInterventions
  • NeuroSigma, Inc.
  • Neurosyntec LLC.
  • NexGen Medical Systems, Inc.
  • NSVascular, Inc.
  • Palmaz Scientific, Inc.
  • Penumbra, Inc.
  • Philips Healthcare
  • PhotoThera, Inc.
  • Pulsar Vascular, Inc.
  • Pulse Therapeutics, Inc.
  • Rapid Medical
  • Reverse Medical
  • Rontis AG
  • Sequent Medical, Inc.
  • Shape Memory Therapeutics, Inc.
  • Silk Road Medical, Inc.
  • Strategic Polymer Sciences, Inc
  • Stryker Corporation
  • Synaptive Medical Inc.
  • テルモ
  • Triticum Medical Ltd.
  • Twin Star Medical, Inc.
  • University of California, San Francisco
  • University of Oxford
  • University of South Florida
  • University of Wisconsin Madison
  • University of Wolverhampton
  • Valor Medical, Inc.
  • Vascular Solutions, Inc.
  • Viket Medical Corporation
  • Zoll Medical Corporation

第6章 インターベンショナル神経学市場:昨今の動向

第7章 付録

図表一覧

目次
Product Code: GDME0132EPD

GlobalData's Medical Devices sector report, "Interventional Neurology - Medical Devices Pipeline Assessment, 2015" provides an overview of Interventional Neurology currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interventional Neurology pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Interventional Neurology under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Interventional Neurology and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Interventional Neurology under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Interventional Neurology Overview

3. Products under Development

  • 3.1. Interventional Neurology - Pipeline Products by Stage of Development
  • 3.2. Interventional Neurology - Pipeline Products by Segment
  • 3.3. Interventional Neurology - Pipeline Products by Territory
  • 3.4. Interventional Neurology - Pipeline Products by Regulatory Path
  • 3.5. Interventional Neurology - Pipeline Products by Estimated Approval Date
  • 3.6. Interventional Neurology - Ongoing Clinical Trials

4. Interventional Neurology - Pipeline Products under Development by Companies

  • 4.1. Interventional Neurology Companies - Pipeline Products by Stage of Development
  • 4.2. Interventional Neurology - Pipeline Products by Stage of Development

5. Interventional Neurology Companies and Product Overview

  • 5.1. Alcyone Lifesciences, Inc. Company Overview
    • 5.1.1. Alcyone Lifesciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Aneuclose LLC Company Overview
    • 5.2.1. Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Apeliotus Technologies Company Overview
    • 5.3.1. Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Arterain Medical Inc. Company Overview
    • 5.4.1. Arterain Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Avantec Vascular Corporation Company Overview
    • 5.5.1. Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Cibiem, Inc. Company Overview
    • 5.6.1. Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Codman & Shurtleff, Inc. Company Overview
    • 5.7.1. Codman & Shurtleff, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Collagen Matrix, Inc. Company Overview
    • 5.8.1. Collagen Matrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Cordis Corporation Company Overview
    • 5.9.1. Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. CranioVation Company Overview
    • 5.10.1. CranioVation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Dartmouth College Company Overview
    • 5.11.1. Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. DePuy Companies Company Overview
    • 5.12.1. DePuy Companies Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. EchoGuide Medical, Inc. Company Overview
    • 5.13.1. EchoGuide Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. EKOS Corporation Company Overview
    • 5.14.1. EKOS Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Gaudi Vascular, Inc. Company Overview
    • 5.15.1. Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview
    • 5.16.1. Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Hibernia Medical Company Overview
    • 5.17.1. Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Insera Therapeutics, LLC Company Overview
    • 5.18.1. Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. InspireMD, Inc. Company Overview
    • 5.19.1. InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. ITGI Medical Ltd. Company Overview
    • 5.20.1. ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Lazarus Effect, Inc Company Overview
    • 5.21.1. Lazarus Effect, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Medikit Co., Ltd. Company Overview
    • 5.22.1. Medikit Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Merlin MD Pte. Ltd. Company Overview
    • 5.23.1. Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Metactive Medical, LLC Company Overview
    • 5.24.1. Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. MicroPort Scientific Corporation Company Overview
    • 5.25.1. MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. MicroVention, Inc. Company Overview
    • 5.26.1. MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. MindFrame Inc. (Inactive) Company Overview
    • 5.27.1. MindFrame Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Neuravi Limited Company Overview
    • 5.28.1. Neuravi Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. NeuroInterventional Therapeutics, Inc. Company Overview
    • 5.29.1. NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. NeuroInterventions Company Overview
    • 5.30.1. NeuroInterventions Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. NeuroSigma, Inc. Company Overview
    • 5.31.1. NeuroSigma, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Neurosyntec LLC. Company Overview
    • 5.32.1. Neurosyntec LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. NexGen Medical Systems, Inc. Company Overview
    • 5.33.1. NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. NSVascular, Inc. Company Overview
    • 5.34.1. NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Palmaz Scientific, Inc. Company Overview
    • 5.35.1. Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Penumbra, Inc. Company Overview
    • 5.36.1. Penumbra, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Philips Healthcare Company Overview
    • 5.37.1. Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. PhotoThera, Inc. Company Overview
    • 5.38.1. PhotoThera, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. Pulsar Vascular, Inc. Company Overview
    • 5.39.1. Pulsar Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Pulse Therapeutics, Inc. Company Overview
    • 5.40.1. Pulse Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. Rapid Medical Company Overview
    • 5.41.1. Rapid Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. Reverse Medical Corporation Company Overview
    • 5.42.1. Reverse Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. Rontis AG Company Overview
    • 5.43.1. Rontis AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. Sequent Medical, Inc. Company Overview
    • 5.44.1. Sequent Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. Shape Memory Therapeutics, Inc. Company Overview
    • 5.45.1. Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. Silk Road Medical, Inc. Company Overview
    • 5.46.1. Silk Road Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. Strategic Polymer Sciences, Inc Company Overview
    • 5.47.1. Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. Stryker Corporation Company Overview
    • 5.48.1. Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. Synaptive Medical Inc. Company Overview
    • 5.49.1. Synaptive Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. Terumo Corporation Company Overview
    • 5.50.1. Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Triticum Medical Ltd. Company Overview
    • 5.51.1. Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Twin Star Medical, Inc. Company Overview
    • 5.52.1. Twin Star Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. University of California, San Francisco Company Overview
    • 5.53.1. University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. University of Oxford Company Overview
    • 5.54.1. University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. University of South Florida Company Overview
    • 5.55.1. University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. University of Wisconsin Madison Company Overview
    • 5.56.1. University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. University of Wolverhampton Company Overview
    • 5.57.1. University of Wolverhampton Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. Valor Medical, Inc. Company Overview
    • 5.58.1. Valor Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59. Vascular Solutions, Inc. Company Overview
    • 5.59.1. Vascular Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60. Viket Medical Corporation Company Overview
    • 5.60.1. Viket Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61. Zoll Medical Corporation Company Overview
    • 5.61.1. Zoll Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview

6. Interventional Neurology- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Interventional Neurology - Pipeline Products by Stage of Development
  • Table 2: Interventional Neurology - Pipeline Products by Segment
  • Table 3: Interventional Neurology - Pipeline Products by Territory
  • Table 4: Interventional Neurology - Pipeline Products by Regulatory Path
  • Table 5: Interventional Neurology - Pipeline Products by Estimated Approval Date
  • Table 6: Interventional Neurology - Ongoing Clinical Trials
  • Table 7: Interventional Neurology Companies - Pipeline Products by Stage of Development
  • Table 8: Interventional Neurology - Pipeline Products by Stage of Development
  • Table 9: Alcyone Lifesciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Alcyone Microcatheter - Product Status
  • Table 11: Alcyone Microcatheter - Product Description
  • Table 12: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Aneurysm Occlusion Saddle - Product Status
  • Table 14: Aneurysm Occlusion Saddle - Product Description
  • Table 15: Janjua Aneurysm Net - Product Status
  • Table 16: Janjua Aneurysm Net - Product Description
  • Table 17: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Polymer Stent for Cerebral Aneurysms - Product Status
  • Table 19: Polymer Stent for Cerebral Aneurysms - Product Description
  • Table 20: Arterain Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Catheter Based System - Product Status
  • Table 22: Catheter Based System - Product Description
  • Table 23: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Endovascular Embolization Device - Product Status
  • Table 25: Endovascular Embolization Device - Product Description
  • Table 26: Ischemic Stroke Therapy Device - Product Status
  • Table 27: Ischemic Stroke Therapy Device - Product Description
  • Table 28: Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Carotid Body Modulation - Product Status
  • Table 30: Carotid Body Modulation - Product Description
  • Table 31: Cibiem, Inc. - Ongoing Clinical Trials Overview
  • Table 32: Carotid Body Modulation - Endovascular Carotid Body Ablation in Patients with Treatment- resistant Hypertension: A Safety and Feasibility Study
  • Table 33: Codman & Shurtleff, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Next Generation REVIVE SE - Product Status
  • Table 35: Next Generation REVIVE SE - Product Description
  • Table 36: Collagen Matrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Collagen-based Coils - Product Status
  • Table 38: Collagen-based Coils - Product Description
  • Table 39: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Flow Diverter - Product Status
  • Table 41: Flow Diverter - Product Description
  • Table 42: CranioVation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: Brain Aneurysm Clip - Product Status
  • Table 44: Brain Aneurysm Clip - Product Description
  • Table 45: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Aneurysm Clip Applicator - Product Status
  • Table 47: Aneurysm Clip Applicator - Product Description
  • Table 48: Cerebral Aneurysm Clip - Product Status
  • Table 49: Cerebral Aneurysm Clip - Product Description
  • Table 50: DePuy Companies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Covered Stent - Product Status
  • Table 52: Covered Stent - Product Description
  • Table 53: Liquid Embolic System - Product Status
  • Table 54: Liquid Embolic System - Product Description
  • Table 55: Next Generation Balloon Expandable Stent - Product Status
  • Table 56: Next Generation Balloon Expandable Stent - Product Description
  • Table 57: Occlusion Balloons - Product Status
  • Table 58: Occlusion Balloons - Product Description
  • Table 59: PHAROS Vitesse Stent - Product Status
  • Table 60: PHAROS Vitesse Stent - Product Description
  • Table 61: REVIVE SE - Product Status
  • Table 62: REVIVE SE - Product Description
  • Table 63: Self-Expanding Stent - Product Status
  • Table 64: Self-Expanding Stent - Product Description
  • Table 65: DePuy Companies - Ongoing Clinical Trials Overview
  • Table 66: PHAROS Vitesse Stent - Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease
  • Table 67: EchoGuide Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: Ultrasound Catheter Navigation Device - Product Status
  • Table 69: Ultrasound Catheter Navigation Device - Product Description
  • Table 70: EKOS Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: EKOS EkoSonic SV System - Neuro Vasculature - Product Status
  • Table 72: EKOS EkoSonic SV System - Neuro Vasculature - Product Description
  • Table 73: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Intracranial Stent - Product Status
  • Table 75: Intracranial Stent - Product Description
  • Table 76: Zippered Microcatheter - Product Status
  • Table 77: Zippered Microcatheter - Product Description
  • Table 78: Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Blood Clots Clearing Device - Product Status
  • Table 80: Blood Clots Clearing Device - Product Description
  • Table 81: Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: Hybernia Safety Catheter - Neuroprotection - Product Status
  • Table 83: Hybernia Safety Catheter - Neuroprotection - Product Description
  • Table 84: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: SHELTER - Product Status
  • Table 86: SHELTER - Product Description
  • Table 87: InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 88: NVGuard Neurovascular - Product Status
  • Table 89: NVGuard Neurovascular - Product Description
  • Table 90: ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: Mechanical Thrombectomy Device - Product Status
  • Table 92: Mechanical Thrombectomy Device - Product Description
  • Table 93: Lazarus Effect, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: Lazarus Cover - Product Status
  • Table 95: Lazarus Cover - Product Description
  • Table 96: Lazarus Lynx - Product Status
  • Table 97: Lazarus Lynx - Product Description
  • Table 98: Lazarus ReCover - Product Status
  • Table 99: Lazarus ReCover - Product Description
  • Table 100: Medikit Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 101: Aspirarecath - Product Status
  • Table 102: Aspirarecath - Product Description
  • Table 103: Axcelguide - Product Status
  • Table 104: Axcelguide - Product Description
  • Table 105: Cerulean G - Product Status
  • Table 106: Cerulean G - Product Description
  • Table 107: Slimguide - Product Status
  • Table 108: Slimguide - Product Description
  • Table 109: Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Next Generation Device For Cerebral Aneurysm - Product Status
  • Table 111: Next Generation Device For Cerebral Aneurysm - Product Description
  • Table 112: X Calibur Aneurysm Occlusion Device - Product Status
  • Table 113: X Calibur Aneurysm Occlusion Device - Product Description
  • Table 114: Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 115: Ballstent Microcatheter - Product Status
  • Table 116: Ballstent Microcatheter - Product Description
  • Table 117: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 118: Blood Clot Removing Device - Product Status
  • Table 119: Blood Clot Removing Device - Product Description
  • Table 120: Micro-Catheter - Product Status
  • Table 121: Micro-Catheter - Product Description
  • Table 122: Tubridge - Product Status
  • Table 123: Tubridge - Product Description
  • Table 124: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 125: ERIC Clot Removal Device - Product Status

List of Figures

  • Figure 1: Interventional Neurology - Pipeline Products by Stage of Development
  • Figure 2: Interventional Neurology - Pipeline Products by Segment
  • Figure 3: Interventional Neurology - Pipeline Products by Territory
  • Figure 4: Interventional Neurology - Pipeline Products by Regulatory Path
  • Figure 5: Interventional Neurology - Pipeline Products by Estimated Approval Date
  • Figure 6: Interventional Neurology - Ongoing Clinical Trials
Back to Top